Xortx Therapeutics: Funding, Investors & Team (Sep 2026)
XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy, and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. Additional information on XORTX Therapeutics is available at www.XORTX.com.
Xortx Therapeutics has raised $17.1M across 6 funding rounds on record, the most recent an undisclosed round of $5.0M announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Xortx Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
Xortx Therapeutics Funding Rounds
Xortx Therapeutics raised $5.0M in a Post-IPO Equity announced in Oct 2022.
1.3 years later, an undisclosed round of $1.5M was announced in Jan 2024.
9 months later, an undisclosed round of $1.5M was announced in Oct 2024.
7 months later, an undisclosed round of $3.0M was announced in May 2025.
5 months later, an undisclosed round of $1.1M was announced in Oct 2025.
7 months later, an undisclosed round of $5.0M was announced in May 2026.
Xortx Therapeutics Founders and Leadership Team
Contact details for the Xortx Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Xortx Therapeutics Funding Compared to Other Biotechnology Startups
Xortx Therapeutics' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Xortx Therapeutics in Biotechnology and Calgary
Companies Similar to Xortx Therapeutics
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Xortx Therapeutics Funding FAQs
What does Xortx Therapeutics do?
XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy, and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. Additional information on XORTX Therapeutics is available at www.XORTX.com.
How much funding has Xortx Therapeutics raised?
Xortx Therapeutics has raised $17.1M across 6 rounds on record. The most recent is an undisclosed round of $5.0M announced in May 2026.
When did Xortx Therapeutics last raise funding?
Xortx Therapeutics' most recent funding round on record is an undisclosed round of $5.0M, announced in May 2026.
Who founded Xortx Therapeutics?
FundedIQ lists Allen Davidoff (Founder), Allen W Davidoff (Founder) at Xortx Therapeutics.
Where is Xortx Therapeutics headquartered?
Xortx Therapeutics is based in Calgary, Alberta, Canada.
How many employees does Xortx Therapeutics have?
Xortx Therapeutics is in the 1-10 employee band.
How does Xortx Therapeutics' funding compare to other Biotechnology startups?
Xortx Therapeutics' latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Xortx Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Xortx Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.